Evidence map›Paper›PMID 42794348›Full record

ReviewGels (Basel, Switzerland)2026

Gelatin Hydrogel Crosslinking: From Molecular Design to Functional Soft Materials.

Pietro Tordi

Abstract readReview
In one paragraph

Review in Gels (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Pietro TordiDepartment of Chemistry "Ugo Schiff" and CSGI, University of Florence, via della Lastruccia 3, 50019 Sesto Fiorentino, Florence, Italy.ORCID 0009-0009-0753-0366

Funding

Consorzio Interuniversitario per lo Sviluppo dei Sistemi a Grande InterfaseMinistero dell'università e della ricerca 58503DIP_ECC
6 · The paper itself

Abstract

Gelatin hydrogels combine biological origin, biodegradability, abundant chemical functionality, and broad processability, but their native thermoreversible physical networks generally lack the stability required for sustained operation. Crosslinking overcomes this limitation while regulating hydration, mechanics, transport, degradation, and responsiveness. This review examines gelatin hydrogel crosslinking from a structure-property-function perspective, connecting molecular design with physicochemical characterization and functional performance. Temperature-induced gelation and ion-mediated physical interactions are compared with small-molecule- and coupling-agent-mediated, enzyme-catalyzed, and photoinduced covalent crosslinking strategies, highlighting their different balances among reversibility, stability, processability, and biocompatibility. Particular attention is given to the characterization methods required to relate junction chemistry and network organization to swelling, thermal behavior, mechanical response, degradation, and molecular or ionic transport. These relationships are evaluated across drug delivery and controlled release, tissue engineering and wound healing, food packaging, preservation and delivery, water remediation and environmental management, wearable sensing and bioelectronics, and energy storage. Across these fields, the central challenge is not to maximize crosslinking, but to balance network stability with the molecular mobility required for function. By integrating complementary crosslinking mechanisms with multiscale characterization, gelatin can be engineered as a programmable platform for advanced soft materials.

Indexed as

crosslinkingdrug releaseenergy storagefood packaginggelatinhydrogelsensingtissue engineeringwater remediation

Identifiers

PMID42794348
PMCPMC13606067

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.